CompletedPhase 4

Comparison of Single-syringe vs. Double-syringe Techniques for Adenosine Administration in PSVT

Iran131 participantsStarted 2024-05-21

Plain-language summary

The purpose of the study is to compare the effectiveness of two different methods of administering adenosine for the treatment of stable supraventricular tachycardia (SVT).

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18 to 80 years * Presentation to the emergency department with narrow-QRS tachyarrhythmia * Heart rate ≥150 beats/min * No visible P wave or presence of retrograde P wave on ECG * Not responsive to Valsalva maneuvers lasting 15 to 30 seconds * Requiring adenosine administration Exclusion Criteria: * Wide-QRS tachycardia or irregular R-R interval on ECG * Known allergy or contraindication to adenosine * Recent ingestion of dipyridamole, carbamazepine, or theophylline * Caffeine ingestion within the previous 2 hours

What they're measuring

First-dose successful termination of PSVT

Timeframe: Within 2 minutes after administration of the first dose of adenosine.

Trial details

NCT IDNCT07554170

SponsorHormozgan University of Medical Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-21

View on ClinicalTrials.gov More Supraventricular Tachycardia trials